Hofseth BioCare ASA
Hofseth BioCare ASA
08/04/2022 | Press release | Distributed by Public on 08/04/2022 04:19
Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED
Tid04.08.2022, 10:09:53
MeldingsID567837
UtstederIDHBC
MarkedOslo Børs
Andre språk
Korrigerte versjoner
KategoriKAPITAL- OG STEMMERETTSENDRINGER
-
Informasjonspliktige opplysningerInformasjonspliktige opplysninger i henhold til lov, forskrift eller børsens egne regler for markedet verdipapiret er notert på.
-
Lagringspliktig meldingMed lagringspliktige meldinger menes meldinger som skal oppbevares i offisiell lagringsmekanisme (OAM) etter verdipapirhandelloven § 5-12 og/eller børsens egne regler.
Vedlegg
Del melding
Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED
In the annual general meeting of Hofseth BioCare ASA (the "Company") held on 29
April 2022, the general meeting resolved to carry out a private placement
towards Brilliant Invest 2 AG as part of an incentive program for certain
consultants and partners of the Company. Further, the Company carried out a
private placement towards various investors on 3 July 2022. In the latter
private placement, the payment dates were set in two tranches with the second
tranche having payment date on 24 July 2022.
The share capital increases pertaining to the two private placements mentioned
above have now been registered in the Norwegian Register of Business
Enterprises. The share capital of the Company has increased with NOK 121,100
through the issuance of 12,110,000 new shares, each with a par value of NOK
0.01.
The new registered share capital of the Company is NOK 3,950,810.30 divided by
395,081,030 shares, each with a par value of NOK 0.01.
For further information, please contact:
Jon Olav Ødegård, CEO at HBC
Phone: +47 936 32 966
E-mail: [email protected]
This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act.
April 2022, the general meeting resolved to carry out a private placement
towards Brilliant Invest 2 AG as part of an incentive program for certain
consultants and partners of the Company. Further, the Company carried out a
private placement towards various investors on 3 July 2022. In the latter
private placement, the payment dates were set in two tranches with the second
tranche having payment date on 24 July 2022.
The share capital increases pertaining to the two private placements mentioned
above have now been registered in the Norwegian Register of Business
Enterprises. The share capital of the Company has increased with NOK 121,100
through the issuance of 12,110,000 new shares, each with a par value of NOK
0.01.
The new registered share capital of the Company is NOK 3,950,810.30 divided by
395,081,030 shares, each with a par value of NOK 0.01.
For further information, please contact:
Jon Olav Ødegård, CEO at HBC
Phone: +47 936 32 966
E-mail: [email protected]
This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act.